aap is granted two European patents for innovative magnesium technology, making great progress in development of resorbable implants

aap Implantate AG / aap is granted two European patents for innovative magnesium technology, making great progress in development of resorbable implants . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

aap Implantate AG (XETRA: AAQ.DE), a developer, manufacturer and distributor of innovative trauma products, announced that the European Patent Office will shortly grant it two key patents for developing resorbable magnesium implants. The first patent (WO2010/017959) will protect an efficient way to manufacture magnesium implants while the second (WO2012/007181) relates to a coating technology for magnesium implants. Final granting of the two patents now depends solely on the fulfilment of formal conditions such as payment of a patent fee. The two European patents will then be nationalised in many key markets in Europe and published in different languages.

In the magnesium technology area aap Implantate AG aims to develop implants that after successful fracture or defect healing are biodegradable in the body, thereby making a second operation to remove the material superfluous. The implant must have high mechanical properties and also be resorbable. In this connection the first patent (WO2010/017959) protects the manufacture of magnesium implants with different porosity. aap Implantate AG has succeeded in manufacturing screws with a very porous core and a highly compacted outer skin. This makes the implant very stable for an initial period during which healing is under way, after which it can degrade relatively fast. The second patent (WO2012/007181) relates to a coating technology for magnesium implants that can influence the beginning of resorption. The essential biomechanical stability of the implant can thus be maintained during healing for as long as is required until healing of the bone is completed.

"The latest research findings and publications have shown especially that the processing and coating of the magnesium are the key to success with resorbable magnesium implants", says Bruke Seyoum Alemu, CEO of aap Implantate AG. "As a result these two patents have enabled us to take a further and significant step forward in expanding our strategic patent-protected portfolio."

aap Implantate AG (ISIN DE0005066609) - Prime Standard/Regulated Market - All German stock markets -